Uses of bioengineering topic of EC presentation

Dennis Bahr

The use of bioengineering to treat cancer and create artificial intelligence are among the topics that will be explored at the 60th annual William Thomas Jackson Lecture in Science at 7:30 p.m. April 1 in the Cerf Center at Eureka College.

The free presentation titled “Bioengineering Unravels the Mysteries of Life” will be given by Dennis Bahr of Middleton, Wis., director of research and development at Helionx LLC. The company is developing an ion accelerator for the production of high energy neutrons for applications in nuclear fusion.

“The combination of biology and engineering has done much to transform our world,” Bahr said. “For example, early investigators used biology and engineering to unravel the structure of DNA and other structures in all living cells.”

Bahr’s presentation will explore how bioengineers designed and build heart defibrillators, pacemakers and oximeters, as well as how they help treat cancer and use individuals’ stem cells to grow new tissue and bone. In the future, Bahr said, bioengineers will help decipher the electrical characteristics of the brain and produce true artificial intelligence.

Bahr formerly was president and CEO of Bahr Management Inc., which designs and markets biomedical instrumentation, software and computer modeling of physical systems.

The Jackson Lecture was established to honor the late William Thomas Jackson, an alumnus of Eureka College who taught chemistry at the college for 36 years. For more information, contact Eureka College computer science professor Keith Tookey at (309) 467-6445.